When these targeted systems are combined with mutations in major oncogenes and tumor suppressor genes (such as Kras, Cdh1, Trp53, and Smad4), the resulting mouse models can faithfully reproduce a range of human gastric cancer subtypes, including both intestinal and diffuse types, with features of metastatic disease. This evidence concerns the gene TP53 and metastatic neoplasm.